The Institute of Molecular and Translational Medicine, Czech Republic   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Czech Republic (2010)

Organization Overview

First Clinical Trial
2015
NCT02314871
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Marian Hajduch, M.D., Ph.D. | The Institute of Molecular and Translational Medicine, Czech Republic